Stock listing
IPSC Stock Price, News, Filings & Events — Century Therapeutics, Inc.
Selected listing: IPSC · NASDAQ · USD · US
The selected listing for Century Therapeutics, Inc. is IPSC:NASDAQ. The company specializes in creating advanced cell therapies aimed at treating cancer, positioning itself in a critical sector of the biotechnology industry. With a market capitalization of around $380.5 million, Century Therapeutics is actively involved in research and development to bring new therapeutic options to patients. Recent news and filings may provide insights into their ongoing projects and strategic direction in the competitive landscape of cancer treatment.
- Ticker
- IPSC:NASDAQ
- Asset type
- Stock
- Market cap
- $380.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Century Therapeutics, Inc. IPSC:NASDAQ stock context
The selected listing for Century Therapeutics, Inc. is IPSC:NASDAQ. The company specializes in creating advanced cell therapies aimed at treating cancer, positioning itself in a critical sector of the biotechnology industry. With a market capitalization of around $380.5 million, Century Therapeutics is actively involved in research and development to bring new therapeutic options to patients. Recent news and filings may provide insights into their ongoing projects and strategic direction in the competitive landscape of cancer treatment.
Research Century Therapeutics, Inc.
Century Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for IPSC:NASDAQ.
Century Therapeutics, Inc. company profile
View the public company page for Century Therapeutics, Inc. on 6ix.
Century Therapeutics, Inc. news
Read company news and market updates connected to Century Therapeutics, Inc..
Century Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Century Therapeutics, Inc..